GBT Presents Data on New Sickle Cell Disease Pipeline Therapies with Best-in-Class Potential – Inclacumab and GBT021601

NEXT STORY
MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 2020 ASH Annual Meeting
PREV STORY
Constellation Pharmaceuticals Provides Update of MANIFEST Study for CPI-0610 at ASH Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CORRECTION FIT Biotech Oy: FIT Biotech’s company site has been launched in Inderes.fi

FIT Biotech Oy                                                                   Press Release July 4th, 2018, 12.30 EET FIT Biotech's company site ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ hGH (Lonapegsomatropin) for Pediatric Growth Hormone Deficiency

author_avatar
NASDAQ Market News

UPDATE — Looking Beyond DNA to See Cancer with New Clarity

author_avatar
NASDAQ Market News